Gentry Leesa
RenovoRx, Inc. · Chief Clinical Officer
Gentry Leesa is listed in public filings as officer: Chief Clinical Officer. This Gentry Leesa insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include RenovoRx, Inc. (RNXT). Investors use Gentry Leesa's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $126k128.6k shares | Grant / ExerciseApr 3, 2026 | $126.0K128.6k shares | $0.98 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $8.4k6.6k shares | Grant / ExerciseJul 1, 2025 | $8.4K6.6k shares | $1.27 | -- | |
| $22k26.5k shares | Grant / ExerciseApr 14, 2025 | $22.4K26.5k shares | $0.8448 | -- |